11.21
price up icon2.56%   0.28
pre-market  Pre-market:  11.99   0.78   +6.96%
loading
Celcuity Inc stock is traded at $11.21, with a volume of 186.57K. It is up +2.56% in the last 24 hours and down -10.03% over the past month. Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
See More
Previous Close:
$10.93
Open:
$10.97
24h Volume:
186.57K
Relative Volume:
0.71
Market Cap:
$416.22M
Revenue:
-
Net Income/Loss:
$-63.78M
P/E Ratio:
-4.1828
EPS:
-2.68
Net Cash Flow:
$-53.91M
1W Performance:
+6.46%
1M Performance:
-10.03%
6M Performance:
-35.13%
1Y Performance:
-24.05%
1-Day Range:
Value
$10.84
$11.36
1-Week Range:
Value
$10.56
$11.69
52-Week Range:
Value
$10.35
$22.19

Celcuity Inc Stock (CELC) Company Profile

Name
Name
Celcuity Inc
Name
Phone
763-392-0767
Name
Address
16305 36TH AVENUE N, MINNEAPOLIS, MN
Name
Employee
55
Name
Twitter
Name
Next Earnings Date
2024-11-11
Name
Latest SEC Filings
Name
CELC's Discussions on Twitter

Compare CELC with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
CELC
Celcuity Inc
11.21 416.22M 0 -63.78M -53.91M -2.68
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
427.89 110.19B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
687.80 75.58B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
647.39 38.71B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
264.99 34.18B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
117.25 28.11B 3.30B -501.07M 1.03B -2.1146

Celcuity Inc Stock (CELC) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-22-24 Initiated Leerink Partners Outperform
Feb-22-24 Initiated Stifel Buy
Dec-08-23 Initiated H.C. Wainwright Buy
Oct-08-21 Initiated Canaccord Genuity Buy
Sep-07-21 Initiated Jefferies Buy
Jul-29-21 Initiated Cowen Outperform
Jul-27-21 Initiated Needham Buy
Jan-28-21 Reiterated H.C. Wainwright Buy
Dec-24-20 Reiterated H.C. Wainwright Buy
May-11-20 Resumed Craig Hallum Buy
Nov-20-18 Initiated H.C. Wainwright Buy
View All

Celcuity Inc Stock (CELC) Latest News

pulisher
Jan 18, 2025

Hennion & Walsh Asset Management Inc. Buys 71,006 Shares of Celcuity Inc. (NASDAQ:CELC) - MarketBeat

Jan 18, 2025
pulisher
Jan 17, 2025

Celcuity Inc. (NASDAQ:CELC) Receives $29.17 Average PT from Analysts - Defense World

Jan 17, 2025
pulisher
Jan 16, 2025

Celcuity Inc. (NASDAQ:CELC) Holdings Raised by Barclays PLC - Defense World

Jan 16, 2025
pulisher
Jan 16, 2025

Celcuity Inc. (NASDAQ:CELC) Shares Bought by Barclays PLC - MarketBeat

Jan 16, 2025
pulisher
Jan 14, 2025

Celcuity Inc. (NASDAQ:CELC) Receives $29.17 Average PT from Brokerages - MarketBeat

Jan 14, 2025
pulisher
Jan 14, 2025

Analyzing Celcuity (NASDAQ:CELC) and CannLabs (OTCMKTS:CANL) - Defense World

Jan 14, 2025
pulisher
Jan 13, 2025

Jane Street Group LLC Sells 9,921 Shares of Celcuity Inc. (NASDAQ:CELC) - Defense World

Jan 13, 2025
pulisher
Jan 10, 2025

Celcuity stock touches 52-week low at $11.51 amid market challenges - Investing.com India

Jan 10, 2025
pulisher
Jan 03, 2025

Objective long/short (CELC) Report - Stock Traders Daily

Jan 03, 2025
pulisher
Jan 02, 2025

Geode Capital Management LLC Acquires 136,518 Shares of Celcuity Inc. (NASDAQ:CELC) - MarketBeat

Jan 02, 2025
pulisher
Jan 02, 2025

Celcuity Inc. (NASDAQ:CELC) Shares Purchased by Geode Capital Management LLC - Defense World

Jan 02, 2025
pulisher
Jan 01, 2025

Celcuity Inc. (NASDAQ:CELC) Shares Acquired by Barclays PLC - Defense World

Jan 01, 2025
pulisher
Jan 01, 2025

Barclays PLC Raises Stock Position in Celcuity Inc. (NASDAQ:CELC) - MarketBeat

Jan 01, 2025
pulisher
Dec 27, 2024

Celcuity (NASDAQ:CELC) Trading Up 3.8%Here's Why - MarketBeat

Dec 27, 2024
pulisher
Dec 25, 2024

State Street Corp Purchases 668,318 Shares of Celcuity Inc. (NASDAQ:CELC) - MarketBeat

Dec 25, 2024
pulisher
Dec 23, 2024

How to Take Advantage of moves in (CELC) - Stock Traders Daily

Dec 23, 2024
pulisher
Dec 23, 2024

Celcuity Inc. (NASDAQ:CELC) Receives $29.17 Consensus Target Price from Analysts - Defense World

Dec 23, 2024
pulisher
Dec 20, 2024

Celcuity Inc. (NASDAQ:CELC) Given Average Rating of "Buy" by Analysts - MarketBeat

Dec 20, 2024
pulisher
Dec 20, 2024

Wellington Management Group LLP Makes New Investment in Celcuity Inc. (NASDAQ:CELC) - MarketBeat

Dec 20, 2024
pulisher
Dec 17, 2024

Mama's Creations Posts Weak Earnings, Joins EVgo, Red Cat Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market SessionCelcuity (NASDAQ:CELC), Apellis Pharmaceuticals (NASDAQ:APLS) - Benzinga

Dec 17, 2024
pulisher
Dec 17, 2024

Celcuity (CELC) Charges Forward with Promising Potential Cancer Treatments - TipRanks

Dec 17, 2024
pulisher
Dec 16, 2024

Celcuity Inc. (NASDAQ:CELC) Short Interest Update - MarketBeat

Dec 16, 2024
pulisher
Dec 15, 2024

Charles Schwab Investment Management Inc. Purchases 153,712 Shares of Celcuity Inc. (NASDAQ:CELC) - Defense World

Dec 15, 2024
pulisher
Dec 13, 2024

(CELC) Investment Report - Stock Traders Daily

Dec 13, 2024
pulisher
Dec 13, 2024

BNP Paribas Financial Markets Raises Holdings in Celcuity Inc. (NASDAQ:CELC) - MarketBeat

Dec 13, 2024
pulisher
Dec 13, 2024

BNP Paribas Financial Markets Has $673,000 Stake in Celcuity Inc. (NASDAQ:CELC) - Defense World

Dec 13, 2024
pulisher
Dec 11, 2024

Celcuity reports survival data for breast cancer drug - Investing.com

Dec 11, 2024
pulisher
Dec 11, 2024

Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in Combination with Palbociclib and Endocrine Therapy at the 2024 San Antonio Breast Cancer Symposium - The Manila Times

Dec 11, 2024
pulisher
Dec 11, 2024

Celcuity Presents Overall Survival Data from Phase 1b Study - GlobeNewswire

Dec 11, 2024
pulisher
Dec 11, 2024

Verition Fund Management LLC Reduces Holdings in Celcuity Inc. (NASDAQ:CELC) - MarketBeat

Dec 11, 2024
pulisher
Nov 30, 2024

Braidwell LP Buys 367,663 Shares of Celcuity Inc. (NASDAQ:CELC) - MarketBeat

Nov 30, 2024
pulisher
Nov 25, 2024

Celcuity Inc. (NASDAQ:CELC) Given Consensus Rating of "Buy" by Brokerages - MarketBeat

Nov 25, 2024
pulisher
Nov 21, 2024

(CELC) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Nov 21, 2024
pulisher
Nov 18, 2024

Celcuity’s (CELC) “Buy” Rating Reiterated at Needham & Company LLC - Defense World

Nov 18, 2024
pulisher
Nov 18, 2024

Celcuity’s (CELC) “Buy” Rating Reiterated at HC Wainwright - Defense World

Nov 18, 2024
pulisher
Nov 16, 2024

Celcuity (NASDAQ:CELC) Receives "Buy" Rating from HC Wainwright - MarketBeat

Nov 16, 2024
pulisher
Nov 15, 2024

Celcuity stock hits 52-week low at $12.14 amid market shifts - Investing.com

Nov 15, 2024
pulisher
Nov 15, 2024

500: Something went wrong - Investing.com India

Nov 15, 2024
pulisher
Nov 15, 2024

Earnings call: Celcuity reports Q3 2024 financials and clinical trial updates - Investing.com

Nov 15, 2024
pulisher
Nov 15, 2024

Celcuity's (CELC) Buy Rating Reaffirmed at Needham & Company LLC - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Celcuity Inc. (NASDAQ:CELC) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 15, 2024
pulisher
Nov 15, 2024

RA Capital Management, L.P. Acquires New Stake in Celcuity Inc - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

Celcuity Inc (CELC) Q3 2024 Earnings Call Highlights: Clinical Milestones and Financial Challenges By GuruFocus - Investing.com Canada

Nov 15, 2024
pulisher
Nov 15, 2024

COMMODORE CAPITAL LP's Strategic Acquisition of Celcuity Inc Sha - GuruFocus.com

Nov 15, 2024
pulisher
Nov 14, 2024

Celcuity Inc. Reports Q3 Progress and Financials - TipRanks

Nov 14, 2024
pulisher
Nov 14, 2024

Celcuity Inc. Reports Third Quarter Financial Results and Provides Corporate Update - The Manila Times

Nov 14, 2024
pulisher
Nov 12, 2024

Celcuity CEO to Present at Stifel and Jefferies Healthcare Conferences This Month | CELC Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 12, 2024

Celcuity Inc. To Present at Upcoming Stifel and Jefferies Investor Conferences - GlobeNewswire

Nov 12, 2024
pulisher
Nov 11, 2024

Long Term Trading Analysis for (CELC) - Stock Traders Daily

Nov 11, 2024
pulisher
Nov 08, 2024

Celcuity (CELC) Scheduled to Post Earnings on Thursday - MarketBeat

Nov 08, 2024
pulisher
Nov 07, 2024

Celcuity Inc. Schedules Release of Third Quarter 2024 Financial Results and Webcast/Conference Call - GlobeNewswire

Nov 07, 2024

Celcuity Inc Stock (CELC) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$21.80
price up icon 4.81%
$73.47
price up icon 2.14%
$22.10
price up icon 16.13%
$367.97
price up icon 2.52%
biotechnology ONC
$218.70
price up icon 4.10%
$117.25
price up icon 4.75%
Cap:     |  Volume (24h):